Jeroan Allison to Glucocorticoids
This is a "connection" page, showing publications Jeroan Allison has written about Glucocorticoids.
Connection Strength
0.609
-
Neogi T, Allison JJ. Suboptimal osteoporosis management: moving beyond detection. J Rheumatol. 2004 Mar; 31(3):413-5.
Score: 0.203
-
Warriner AH, Outman RC, Allison JJ, Curtis JR, Markward NJ, Redden DT, Safford MM, Stanek EJ, Steinkellner AR, Saag KG. An Internet-based Controlled Trial Aimed to Improve Osteoporosis Prevention among Chronic Glucocorticoid Users. J Rheumatol. 2015 Aug; 42(8):1478-83.
Score: 0.111
-
Curtis JR, Westfall AO, Allison J, Freeman A, Kovac SH, Saag KG. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiol Drug Saf. 2006 Oct; 15(10):710-8.
Score: 0.061
-
Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006 Jun 15; 55(3):420-6.
Score: 0.059
-
Curtis JR, Westfall AO, Allison JJ, Freeman A, Saag KG. Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users. Osteoporos Int. 2006; 17(8):1268-74.
Score: 0.059
-
Curtis JR, Westfall AO, Allison JJ, Becker A, Casebeer L, Freeman A, Spettell CM, Weissman NW, Wilke S, Saag KG. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum. 2005 Aug; 52(8):2485-94.
Score: 0.056
-
Mudano A, Allison J, Hill J, Rothermel T, Saag K. Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. J Rheumatol. 2001 Jun; 28(6):1298-305.
Score: 0.042
-
Curtis JR, Arora T, Xi J, Silver A, Allison JJ, Chen L, Saag KG, Schenck A, Westfall AO, Col?n-Emeric C. Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research. Osteoporos Int. 2009 Nov; 20(11):1921-7.
Score: 0.018